These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7187246)

  • 21. Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder, and psychotic mood disorders.
    Keck PE; Wilson DR; Strakowski SM; McElroy SL; Kizer DL; Balistreri TM; Holtman HM; DePriest M
    J Clin Psychiatry; 1995 Oct; 56(10):466-70. PubMed ID: 7559373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Complementary neurolepsy].
    Petrilowitsch N; Herzog R
    Psychiatr Neurol (Basel); 1966; 151(4):195-207. PubMed ID: 5925592
    [No Abstract]   [Full Text] [Related]  

  • 23. [Evaluation of the therapeutic effect of Vesitan].
    Cwiertnia T
    Psychiatr Pol; 1968; 2(6):639-44. PubMed ID: 5730288
    [No Abstract]   [Full Text] [Related]  

  • 24. Thioproperazine ("Majeptil"), therapeutic results and complications in 63 patients with functional psychoses.
    Lien JB
    Acta Psychiatr Scand; 1967; 43(3):318-40. PubMed ID: 4385555
    [No Abstract]   [Full Text] [Related]  

  • 25. Silent myocardial infarction in a chronic psychotic population.
    Wolpert A; Yaryura-Tobias JA; Kertzner L
    Dis Nerv Syst; 1971 Apr; 32(4):280-3. PubMed ID: 5089995
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical experience with insulin resistance, diabetic ketoacidosis, and type 2 diabetes mellitus in patients treated with atypical antipsychotic agents.
    Henderson DC
    J Clin Psychiatry; 2001; 62 Suppl 27():10-4; discussion 40-1. PubMed ID: 11806484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lithium concentration correlates with QTc in patients with psychosis.
    Mamiya K; Sadanaga T; Sekita A; Nabeyama Y; Yao H; Yukawa E
    J Electrocardiol; 2005 Apr; 38(2):148-51. PubMed ID: 15892025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patterns and frequency of atypical antipsychotic prescribing in psychiatric medical centers: a cross-sectional national survey.
    Diatta T; Blazejewski S; Portier A; Lignot S; Quesnot A; Moore N; Fourrier-Réglat A
    Fundam Clin Pharmacol; 2007 Aug; 21(4):371-8. PubMed ID: 17635175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cooperation of clinical and practical medicine in the long-term drug therapy of patients with psychoses].
    Helmchen H; Hippius H; Tiling P
    Internist (Berl); 1967 Sep; 8(9):328-31. PubMed ID: 4872941
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical report on a high potency neuroleptic agent with certain specific 24-hour-effect after oral administration].
    Zick WH
    Med Welt; 1969 Jul; 30():1659-61. PubMed ID: 5355657
    [No Abstract]   [Full Text] [Related]  

  • 31. [Study of the action of thioridazine in various chronic depressive and dissociative psychoses].
    Soulairac A; Geier S; De Mijolla A; Berouti R
    Ann Med Psychol (Paris); 1967 Feb; 125(2):258-67. PubMed ID: 6050432
    [No Abstract]   [Full Text] [Related]  

  • 32. [Oxyhemometric studies of patients with schizophrenia and reactive psychoses while treating them with neuroleptics].
    Timofeev NN; Kondrashenko VT; Nemtseva NIa
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(6):906-13. PubMed ID: 5723252
    [No Abstract]   [Full Text] [Related]  

  • 33. Observations on Melleril-induced EEG changes in mental patients and their relationship to course and outcome of the illness.
    Robinson S; Dasberg H
    Isr Ann Psychiatr Relat Discip; 1969 Nov; 7(2):201-12. PubMed ID: 5274358
    [No Abstract]   [Full Text] [Related]  

  • 34. Use of oral and injectable phenothiazines in treatment of psychotic patients.
    Yorke ET
    Dis Nerv Syst; 1967 Oct; 28(10):667-70. PubMed ID: 4860894
    [No Abstract]   [Full Text] [Related]  

  • 35. The mono-amine oxidase inhibitors; their usefulness and their safety.
    Bucci L
    Dis Nerv Syst; 1969 Dec; 30(12):843-7. PubMed ID: 5369136
    [No Abstract]   [Full Text] [Related]  

  • 36. [The effects of adrenergic blocking agents on psychotic patients].
    Atsmon A; Blum I; Maoz B; Steiner M; Wysenbeek H
    Harefuah; 1970 Jul; 79(1):20-1. PubMed ID: 5496944
    [No Abstract]   [Full Text] [Related]  

  • 37. [Drug treatment of schizophrenic psychoses in puerperium].
    Olbrich HM; Martin P
    Nervenarzt; 1994 Jul; 65(7):482-5. PubMed ID: 7800093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Review of the evidence for the long-term efficacy of atypical antipsychotic agents in the treatment of patients with schizophrenia and related psychoses.
    Turner MS; Stewart DW
    J Psychopharmacol; 2006 Nov; 20(6 Suppl):20-37. PubMed ID: 17046985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Partial response to antipsychotic treatment: the patient with enduring symptoms.
    Emsley RA
    J Clin Psychiatry; 1999; 60 Suppl 23():10-3. PubMed ID: 10625194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amisulpride doses and plasma levels in different age groups of patients with schizophrenia or schizoaffective disorder.
    Müller MJ; Eich FX; Regenbogen B; Sachse J; Härtter S; Hiemke C
    J Psychopharmacol; 2009 May; 23(3):278-86. PubMed ID: 18562411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.